Chris Viehbacher, Biogen CEO (Suzanne Kreiter/The Boston Globe via Getty Images)
Biogen CEO seeks 'awful lot more collaborations' to beef up R&D as it launches postpartum depression, Alzheimer's and ALS drugs
Biogen CEO Chris Viehbacher said the famed Boston biotech is ready to do “an awful lot more collaborations” as it seeks to fill out its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
